Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Oxford BioMedica ( (GB:OXB) ) has provided an update.
Oxford BioMedica PLC has announced a change in its major shareholders, with Briarwood Chase Management LLC acquiring a significant increase in voting rights, now holding 12.019% of the total. This acquisition indicates a strengthened position for Briarwood Chase Management in the company, potentially influencing future strategic decisions and impacting stakeholder interests.
More about Oxford BioMedica
Oxford BioMedica PLC is a UK-based company operating in the biotechnology industry, primarily focusing on the development and commercialization of gene and cell therapy products. The company is known for its innovative approaches in the field of genetic medicine, targeting various diseases with unmet medical needs.
YTD Price Performance: -21.40%
Average Trading Volume: 19,149
Technical Sentiment Signal: Buy
Current Market Cap: $432.5M
Find detailed analytics on OXB stock on TipRanks’ Stock Analysis page.